20/04/2014 14:46:43 Free Membership Login

Mylan News (NASDAQ:MYL)

DateTimeSource
Headline
04/18/20148:45PMPRNUSSupreme Court Chief Justice Denies Teva's Request for an Injunction Relating to Generic Copaxone®; Clears Legal Hurdle for M...
Supreme Court Chief Justice Denies Teva's Request for an Injunction Relating to Generic Copaxone®; Clears Legal Hurdle for Mylan to Launch at Market Formation PR Newswire PITTSBURGH, April 18, 2014 PITTSBURGH, April 18, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that Supreme Court Chief Justice Roberts... More...>>
04/16/20144:13PMPRNUSMylan Launches First Generic ORTHO EVRA® Patch
Mylan Launches First Generic ORTHO EVRA® Patch PR Newswire PITTSBURGH, April 16, 2014 PITTSBURGH, April 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched XULANE™ (Norelgestromin / Ethinyl Estradiol Transdermal System 150/35 mcg per... More...>>
04/15/201410:20AMPRNUSMylan Announces Settlement Agreement for First-to-File Generess® Fe
Mylan Announces Settlement Agreement for First-to-File Generess® Fe PR Newswire PITTSBURGH, April 15, 2014 PITTSBURGH, April 15, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that it and its partner Famy Care Ltd. have entered into a settlement and license agreement with Warner Chilcott Company, LLC, settling... More...>>
04/15/201410:08AMPRNUSMylan Launches Generic Lunesta® Tablets
Mylan Launches Generic Lunesta® Tablets PR Newswire PITTSBURGH, April 15, 2014 PITTSBURGH, April 15, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Eszopiclone Tablets 1 mg, 2 mg and 3 mg, the generic version of Sunovion Pharmaceuticals Inc.'s Lunesta®. Mylan received final approval... More...>>
04/15/20148:00AMPRNUSProsonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled Respiratory Products Flixotide® and...
Prosonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled Respiratory Products Flixotide® and Flovent® PR Newswire OXFORD, England and PITTSBURGH, Pennsylvania, April 15, 2014 OXFORD, England and PITTSBURGH, Pennsylvania, April 15, 2014 /PRNewswire/ -- Prosonix, an innovative speciality... More...>>
04/15/20148:00AMPRNUSProsonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled Respiratory Products Flixotide® and...
Prosonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled Respiratory Products Flixotide® and Flovent® PR Newswire OXFORD, England and PITTSBURGH, Pennsylvania, April 15, 2014 OXFORD, England and PITTSBURGH, Pennsylvania, April 15, 2014 /PRNewswire/ -- Prosonix, an innovative speciality... More...>>
04/15/20148:00AMPRNUSProsonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled Respiratory Products Flixotide® and...
Prosonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled Respiratory Products Flixotide® and Flovent® PR Newswire OXFORD, England and PITTSBURGH, April 15, 2014 OXFORD, England and PITTSBURGH, April 15, 2014 /PRNewswire/ -- Prosonix, an innovative speciality pharmaceutical company developing... More...>>
04/11/20148:00AMPRNUSCampaign for Wider Reach, Clinical Trial Results, Recognitions, Earnings Release Schedule, and Favorable Ruling - Analyst Not...
Campaign for Wider Reach, Clinical Trial Results, Recognitions, Earnings Release Schedule, and Favorable Ruling - Analyst Notes on Cigna, Medtronic, WellPoint, Mylan, and Express Scripts Editor Note: For more information about this release, please scroll to bottom. PR Newswire NEW YORK, April 11, 2014 NEW YORK, April 11... More...>>
04/11/20147:30AMPRNUSFederal Judge Enforces Settlement Agreement Between Mylan and Endo Regarding Generic FROVA®
Federal Judge Enforces Settlement Agreement Between Mylan and Endo Regarding Generic FROVA® PR Newswire PITTSBURGH, April 11, 2014 PITTSBURGH, April 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals... More...>>
04/10/201412:30PMPRNUSPharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines
Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines Editor Note: For more information about this release, please scroll to bottom PR Newswire LONDON, April 10, 2014 LONDON, April 10, 2014 /PRNewswire/ -- On Wednesday, April 09, 2014, the NASDAQ Composite ended at 4,183.90, up 1.72%, the Dow... More...>>
04/08/20144:24PMPRNUSMylan Schedules First Quarter 2014 Financial Results Conference Call and Live Webcast
Mylan Schedules First Quarter 2014 Financial Results Conference Call and Live Webcast PR Newswire PITTSBURGH, April 8, 2014 PITTSBURGH, April 8, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it will host a conference call and live webcast on Thursday, May 1, 2014, at 11 a.m. ET, to review the company's... More...>>
04/07/20148:00AMPRNUSDrug Recommendations, Legal Updates, Awards, Stock Price Movements, and Upcoming Results and Conference Call Schedules - Anal...
Drug Recommendations, Legal Updates, Awards, Stock Price Movements, and Upcoming Results and Conference Call Schedules - Analyst Notes on MannKind, Mylan, WellPoint, Valeant, and Forest Laboratories Editor Note: For more information about this release, please scroll to bottom. PR Newswire NEW YORK, April 7, 2014 NEW YORK... More...>>
04/04/20144:59PMDJNMARKET SNAPSHOT: U.S. Stocks Sell Off; Nasdaq Drop Worst In 2 Months
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks fell sharply, after heavy selling in momentum stocks such as biotechs and Internet companies on Friday reversed an early rally, sending the Nasdaq Composite to its worst day in two months. The markets opened higher following a government report showing... More...>>
04/04/20144:40PMDJNMARKET SNAPSHOT: U.S. Stocks Sell Off; Nasdaq Drop Worst In 2 Months
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks fell sharply, after heavy selling in momentum stocks such as biotechs and Internet companies on Friday reversed an early rally, sending the Nasdaq Composite to its worst day in two months. The markets opened higher following a government report showing... More...>>
04/04/20143:28PMDJNMARKET SNAPSHOT: Nasdaq Risks Worst Day In 2 Months As High-flyers Drop
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- Selling in the U.S. stock market accelerated on Friday afternoon after a sharp drop in the prices of once high-flying technology and biotech stocks spilled over to wider market. The Nasdaq Composite fell 2.6% and is on track to record a second weekly loss in a row... More...>>
04/04/20142:24PMDJNMARKET SNAPSHOT: Nasdaq Risks Worst Day In 2 Months As High-flyers Drop
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks fell on Friday as sharp drops in once high-flying technology and biotech stocks dragged the rest of the market down. The Nasdaq Composite fell 2.3% and is on track to record a second weekly loss in a row. Closing at this level would mean the worst day... More...>>
04/04/201412:24PMDJNMARKET SNAPSHOT: U.S. Stocks Turn Lower; Nasdaq Down 1.4%
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks turned lower by late morning on Friday as optimism following a government report showing a steady pace of jobs growth dissipated. The economy created slightly fewer jobs in March than forecast, but more jobs were added in January and February than earlier... More...>>
04/04/201412:01PMDJNMARKET SNAPSHOT: U.S. Stocks Turn Lower; Nasdaq Down 1.4%
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks turned lower by late morning on Friday as optimism following a government report showing a steady pace of jobs growth dissipated. The economy created slightly fewer jobs in March than forecast, but more jobs were added in January and February than earlier... More...>>
04/04/201411:15AMDJNMARKET SNAPSHOT: U.S. Stocks Edge Higher On Steady Jobs Growth
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks traded mostly higher on Friday after a government report showed a steady pace of jobs growth that is likely to keep monetary policy and tapering unchanged for the foreseeable future. The economy created slightly fewer jobs in March than forecast, but... More...>>
04/04/201411:12AMDJNMARKET SNAPSHOT: U.S. Stocks Edge Higher On Steady Jobs Growth
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks traded mostly higher on Friday after a government report showed a steady pace of jobs growth that is likely to keep monetary policy and tapering unchanged for the foreseeable future. The economy created slightly fewer jobs in March than forecast, but... More...>>


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq myl140420 14:46